- Home
- RNW vs OCUL Comparison
RNW vs OCUL Comparison
Compare RNW & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNW | OCUL |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | RNW | OCUL |
|---|---|---|
| Price | $7.58 | $11.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $7.83 | ★ $22.33 |
| AVG Volume (30 Days) | 1.1M | ★ 2.4M |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 413.66 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $1,382,164,625.00 | $55,783,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.58 | $17.75 |
| P/E Ratio | $29.00 | ★ N/A |
| Revenue Growth | ★ 46.76 | N/A |
| 52 Week Low | $5.42 | $5.79 |
| 52 Week High | $8.24 | $13.85 |
Technical Indicators
Market Signals| Indicator | RNW | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 52.62 | 43.64 |
| Support Level | $7.22 | $11.63 |
| Resistance Level | $7.69 | $12.27 |
| Average True Range (ATR) | 0.11 | 0.58 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 77.66 | 12.88 |
Price Performance
Historical ComparisonAbout RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.